SMS Pharmaceuticals Limited (SMSPHARMA.BO)

INR 243.5

(0.47%)

Total Debt Summary of SMS Pharmaceuticals Limited

SMS Pharmaceuticals Limited's latest annual total debt in 2023 was 2.8 Billion INR , up 10.51% from previous year.
SMS Pharmaceuticals Limited's latest quarterly total debt in 2023 FY was 2.8 Billion INR , up 10.51% from previous quarter.
SMS Pharmaceuticals Limited reported annual total debt of 2.54 Billion INR in 2022, down -3.5% from previous year.
SMS Pharmaceuticals Limited reported annual total debt of 2.63 Billion INR in 2021, up 3.41% from previous year.
SMS Pharmaceuticals Limited reported quarterly total debt of - INR for 2023 Q3, down -100.0% from previous quarter.
SMS Pharmaceuticals Limited reported quarterly total debt of 2.76 Billion INR for 2023 Q2, down 0.0% from previous quarter.

Annual Total Debt Chart of SMS Pharmaceuticals Limited (2023 - 2004)

Historical Annual Total Debt of SMS Pharmaceuticals Limited (2023 - 2004)

Year	Total Debt	Total Debt Growth
2023	2.8 Billion INR	10.51%
2022	2.54 Billion INR	-3.5%
2021	2.63 Billion INR	3.41%
2020	2.54 Billion INR	62.08%
2019	1.57 Billion INR	9.25%
2018	1.43 Billion INR	-1.62%
2017	1.46 Billion INR	-2.01%
2016	1.49 Billion INR	-11.26%
2015	1.68 Billion INR	10.47%
2014	1.52 Billion INR	1.52%
2013	1.49 Billion INR	14.24%
2012	1.31 Billion INR	-26.94%
2011	1.79 Billion INR	8.03%
2010	1.66 Billion INR	1.77%
2009	1.63 Billion INR	19.0%
2008	1.37 Billion INR	49.62%
2007	917.29 Million INR	47.54%
2006	621.71 Million INR	-4.95%
2005	654.08 Million INR	4.11%
2004	628.23 Million INR	0.0%

Year	Total Debt	Total Debt Growth
2023 Q1	- INR	-100.0%
2023 Q3	- INR	-100.0%
2023 Q2	2.76 Billion INR	0.0%
2023 FY	2.8 Billion INR	10.51%
2023 Q4	2.8 Billion INR	0.0%
2022 Q3	- INR	-100.0%
2022 Q4	2.54 Billion INR	0.0%
2022 FY	2.54 Billion INR	-3.5%
2022 Q1	- INR	-100.0%
2022 Q2	2.53 Billion INR	0.0%
2021 Q4	2.63 Billion INR	0.0%
2021 Q1	- INR	-100.0%
2021 Q3	- INR	-100.0%
2021 Q2	2.46 Billion INR	0.0%
2021 FY	2.63 Billion INR	3.41%
2020 Q2	1.45 Billion INR	0.0%
2020 FY	2.54 Billion INR	62.08%
2020 Q4	2.54 Billion INR	0.0%
2019 FY	1.57 Billion INR	9.25%
2019 Q2	1.18 Billion INR	0.0%
2019 Q4	1.57 Billion INR	0.0%
2018 FY	1.43 Billion INR	-1.62%
2018 Q4	1.43 Billion INR	0.0%
2017 FY	1.46 Billion INR	-2.01%
2016 Q2	1.56 Billion INR	0.0%
2016 FY	1.49 Billion INR	-11.26%
2015 Q4	1.68 Billion INR	0.0%
2015 FY	1.68 Billion INR	10.47%
2015 Q2	1.75 Billion INR	0.0%
2014 Q4	1.52 Billion INR	0.0%
2014 Q2	1.45 Billion INR	0.0%
2014 FY	1.52 Billion INR	1.52%
2013 Q4	1.49 Billion INR	0.0%
2013 FY	1.49 Billion INR	14.24%
2013 Q2	1.23 Billion INR	0.0%
2012 FY	1.31 Billion INR	-26.94%
2012 Q4	1.31 Billion INR	0.0%
2011 FY	1.79 Billion INR	8.03%
2011 Q4	1.79 Billion INR	0.0%
2010 FY	1.66 Billion INR	1.77%
2009 FY	1.63 Billion INR	19.0%
2008 FY	1.37 Billion INR	49.62%
2007 FY	917.29 Million INR	47.54%
2006 FY	621.71 Million INR	-4.95%
2005 FY	654.08 Million INR	4.11%
2004 FY	628.23 Million INR	0.0%

Peer Total Debt Comparison of SMS Pharmaceuticals Limited

Name	Total Debt	Total Debt Difference
Abbott India Limited	832.3 Million INR	-237.343%
Cipla Limited	5.59 Billion INR	49.81%
Gland Pharma Limited	3.72 Billion INR	24.558%
GlaxoSmithKline Pharmaceuticals Limited	186.65 Million INR	-1404.262%
Kopran Limited	992.28 Million INR	-182.953%
Marksans Pharma Limited	2.44 Billion INR	-15.041%
NGL Fine-Chem Limited	324.42 Million INR	-765.443%
Pfizer Limited	945.4 Million INR	-196.986%
Sanofi India Limited	190 Million INR	-1377.739%